Product Information
EVEROLIMUS 10 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $26.3242 per EA under NDC 70377001323. Its NADAC has been published 96 times since Aug 28, 2024.
Strength
10 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377001323
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA214182On Market Since
10/1/2021
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 10 MG TABLET has been published 96 times since Aug 28, 2024, and over the history we have for it it has declined 25.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.3242 per EA |
|---|---|
| All-time high | $43.9175 (Jun 11, 2025) |
| All-time low | $26.3242 (Jan 21, 2026) |
| 52-week high | $42.6095 |
| 52-week low | $26.3242 |
| Median price | $29.5388 |
| Average price | $32.8369 |
| Largest weekly change | +24.8% (Dec 18, 2024) |
| Weeks tracked | 96 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 10 MG TABLET, manufactured by Biocon Pharma Inc., is $26.3242 per EA (NDC 70377001323), effective Jun 24, 2026.
How has the price of EVEROLIMUS 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 10 MG TABLET has declined 25.6%. It has been tracked across 96 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 10 MG TABLET?
Since Aug 28, 2024, the NADAC for EVEROLIMUS 10 MG TABLET has ranged from a low of $26.3242 (Jan 21, 2026) to a high of $43.9175 (Jun 11, 2025), with a median of $29.5388 per EA.
Are there cheaper alternatives to EVEROLIMUS 10 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 10 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 10 MG TABLET?
EVEROLIMUS 10 MG TABLET (NDC 70377001323) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification